In summary, our findings suggest that LEF1 expression contributes to the tumor‐promoting abilities of breast CAFs and that LEF1‐expressing CAFs may drive transdifferentiation toward SCC, possibly through a pathway independent of the canonical Wnt/β‐catenin signaling. Here, LEF1 is linked to neoplasm.